Literature DB >> 12366464

Antipsychotic polypharmacy: evidence based or eminence based?

S M Stahl.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12366464     DOI： 10.1034/j.1600-0447.2002.2e011.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN： 0001-690X            Impact factor:   6.392


× No keyword cloud information.
  24 in total

1.  Augmentation of olanzapine in treatment-resistant schizophrenia.

Authors:  Mathias Zink
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

2.  Meta-analyses: a method to maximise the evidence from clinical studies?

Authors:  Wolfgang Maier; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02       Impact factor: 5.270

3.  Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis.

Authors:  Britta Galling; Alexandra Roldán; Katsuhiko Hagi; Liz Rietschel; Frozan Walyzada; Wei Zheng; Xiao-Lan Cao; Yu-Tao Xiang; Mathias Zink; John M Kane; Jimmi Nielsen; Stefan Leucht; Christoph U Correll
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

4.  Risk factors for non-adherence to antidepressant treatment in patients with mood disorders.

Authors:  Carlos De las Cuevas; Wenceslao Peñate; Emilio J Sanz
Journal:  Eur J Clin Pharmacol       Date:  2013-09-08       Impact factor: 2.953

Review 5.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior.

Authors:  Christoph U Correll; Ladan Shaikh; Juan A Gallego; Jeffrey Nachbar; Vladimir Olshanskiy; Taishiro Kishimoto; John M Kane
Journal:  Schizophr Res       Date:  2011-03-21       Impact factor: 4.939

Review 7.  [Augmenting atypical antipsychotic medications with clozapin].

Authors:  M Zink; H Dressing
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

8.  Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study.

Authors:  Jonathan Brett; Benjamin Daniels; Emily A Karanges; Nicholas A Buckley; Carl Schneider; Atheer Nassir; Andrew J McLachlan; Sallie-Anne Pearson
Journal:  Br J Clin Pharmacol       Date:  2017-08-16       Impact factor: 4.335

9.  Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials.

Authors:  Christoph U Correll; Christine Rummel-Kluge; Caroline Corves; John M Kane; Stefan Leucht
Journal:  Schizophr Bull       Date:  2008-04-15       Impact factor: 9.306

Review 10.  Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice.

Authors:  Christoph U Correll; Juan A Gallego
Journal:  Psychiatr Clin North Am       Date:  2012-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.